We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.75%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$19.2M
(-15%)
Cap. Flow
-$10.6M
Cap. Flow
% of AUM
-9.95%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
95
New
4
Increased
12
Reduced
47
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TriSalus Life Sciences
TLSI
|
+$1.13M |
| 2 |
Safe Pro Group Inc
SPAI
|
+$1.12M |
| 3 |
MDxHealth
MDXH
|
+$331K |
| 4 |
Backblaze
BLZE
|
+$254K |
| 5 |
QuickLogic
QUIK
|
+$253K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SkyWater Technology
SKYT
|
+$3.15M |
| 2 |
Axogen
AXGN
|
+$1.93M |
| 3 |
Digital Turbine
APPS
|
+$1.83M |
| 4 |
Velo3D Inc
VELO
|
+$1.2M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
+$783K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.97% |
| 2 | Technology | 23.53% |
| 3 | Communication Services | 6.22% |
| 4 | Industrials | 3.76% |
| 5 | Energy | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Natera
NTRA
$58.3B
| $8.86M | 8.3% |
44,300
-250
| -0.6% | -$53.8K |
2018 Q2
31 quarters
|
|
2
Eli Lilly
LLY
$1.12T
| $8.12M | 7.61% |
8,830
-135
| -2% | -$137K |
2013 Q2
51 quarters
|
|
|
3
Axogen
AXGN
$2.09B
| $5.59M | 5.24% |
168,842
-59,492
| -26% | -$1.93M |
2013 Q3
50 quarters
|
|
4
Idexx Laboratories
IDXX
$43.1B
| $5.45M | 5.11% |
9,700
| – | – |
2013 Q3
50 quarters
|
|
5
Microsoft
MSFT
$4.01T
| $4.23M | 3.96% |
11,415
-800
| -7% | -$335K |
2014 Q1
48 quarters
|
|
6
Butterfly Network
BFLY
$2.09B
| $3.76M | 3.52% |
930,930
+7,150
| +0.8% | +$27.6K |
2025 Q1
4 quarters
|
|
7
Ciena
CIEN
$50.6B
| $3.45M | 3.23% |
6,300
| – | – |
2018 Q4
29 quarters
|
|
|
8
MDxHealth
MDXH
$57.6M
| $3.4M | 3.18% |
1,476,441
+97,500
| +7% | +$331K |
2021 Q4
17 quarters
|
|
9
Advanced Micro Devices
AMD
$918B
| $3.15M | 2.96% |
15,504
-2,150
| -12% | -$459K |
2018 Q1
32 quarters
|
|
|
10
QuickLogic
QUIK
$171M
| $2.88M | 2.7% |
306,706
+31,000
| +11% | +$253K |
2019 Q2
27 quarters
|
|
11
LeMaitre Vascular
LMAT
$1.9B
| $2.82M | 2.64% |
25,825
-3,075
| -11% | -$293K |
2022 Q3
14 quarters
|
|
12
Ooma
OOMA
$565M
| $2.64M | 2.47% |
181,250
-1,000
| -0.5% | -$12.5K |
2018 Q2
31 quarters
|
|
13
Veracyte
VCYT
$3.57B
| $2.43M | 2.27% |
75,333
-100
| -0.1% | -$3.7K |
2018 Q1
32 quarters
|
|
14
Abbott
ABT
$181B
| $2.12M | 1.99% |
20,659
-750
| -4% | -$84.7K |
2014 Q1
48 quarters
|
|
15
Alphatec Holdings
ATEC
$1.69B
| $1.87M | 1.75% |
171,847
+100
| +0.1% | +$1.46K |
2019 Q3
26 quarters
|
|
16
Ondas Inc
ONDS
$3.7B
| $1.83M | 1.71% |
201,983
-550
| -0.3% | -$5.98K |
2025 Q2
3 quarters
|
|
17
CryoPort
CYRX
$865M
| $1.68M | 1.58% |
203,247
-750
| -0.4% | -$6.78K |
2016 Q1
40 quarters
|
|
18
Neogen
NEOG
$2.68B
| $1.65M | 1.55% |
178,000
-1,250
| -0.7% | -$12.3K |
2025 Q4
1 quarter
|
|
19
Perion Network
PERI
$358M
| $1.57M | 1.47% |
156,865
+18,490
| +13% | +$167K |
2021 Q1
20 quarters
|
|
20
Personalis
PSNL
$1.7B
| $1.52M | 1.43% |
239,000
| – | – |
2024 Q2
7 quarters
|
|
21
Magnite
MGNI
$3.51B
| $1.42M | 1.33% |
119,275
-2,500
| -2% | -$33.5K |
2018 Q2
31 quarters
|
|
22
Lucid Diagnostics
LUCD
$99.3M
| $1.29M | 1.21% |
1,126,000
| – | – |
2025 Q3
2 quarters
|
|
23
Inogen
INGN
$167M
| $1.23M | 1.16% |
199,600
-18,050
| -8% | -$111K |
2025 Q2
3 quarters
|
|
24
Inuvo
INUV
$7.58M
| $1.21M | 1.13% |
582,291
-3,000
| -0.5% | -$7.34K |
2018 Q2
31 quarters
|
|
25
Crexendo
CXDO
$188M
| $1.2M | 1.13% |
194,850
| – | – |
2024 Q4
5 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Perkins Capital Management held 95 positions worth $107M, down 15% from $126M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Perkins Capital Management withdrew a net $10.6M in Q1 2026, closing 9 positions and reducing 47 holdings. Its most notable exit was Digital Turbine, an estimated $1.83M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 64% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in TriSalus Life Sciences worth $920K.
- Perkins Capital Management's largest Q1 2026 buy was TriSalus Life Sciences: 230,101 shares worth $920K.
- Perkins Capital Management added most to MDxHealth in Q1 2026, an estimated $331K increase.
- Perkins Capital Management's biggest Q1 2026 reduction was SkyWater Technology, cutting an estimated $3.15M.
- Perkins Capital Management fully exited Digital Turbine in Q1 2026, selling an estimated $1.83M.
- Perkins Capital Management's ten largest holdings make up 46% of its $107M portfolio in Q1 2026.
- Perkins Capital Management opened 4 new positions and closed 9 in Q1 2026.
- Perkins Capital Management's portfolio value fell 15% quarter-over-quarter to $107M.
Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.